4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-057053
Director bought 43,134 shares at an average $0.94 ($40,546)
From the SEC's structured data for this filing
Trades in this filing
Lamond David · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-29 | Purchase : show line 1 in the form | +14,378 | $0.98 | $14,090 | 2,193,539 | I |
| 2023-11-30 | Purchase : show line 2 in the form | +14,378 | $0.90 | $12,940 | 2,207,917 | I |
| 2023-12-01 | Purchase : show line 3 in the form | +14,378 | $0.94 | $13,515 | 2,222,295 | I |
| Open-market purchases · 43,134 sh · avg $0.94 · $40,546 | ||||||
Loading xslF345X05/doc4.xml…